Hello and Welcome to Patientsville.com, Your Source for all METHERGINE information. We are dedicated to provide You with METHERGINE safety information. Learn about METHERGINE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
METHERGINE Safety Reports
Total METHERGINE reports: 40.METHERGINE FDA safety alerts: No.
Reported hospitalizations: 13.
Take METHERGINE Side Effects Survey or Share Your METHERGINE Story. Read More Here.
Pharmacist from UNITED STATES reported METHERGINE problem on Jan 17, 2007. Female patient, 29 years of age, weighting 143.0 lb, was diagnosed with postpartum haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: body temperature increased, chills, complication of delivery, cyanosis, dyspnoea, livedo reticularis, tachycardia. METHERGINE dosage: 0.2 MG, ONCE/SINGLE. During the same period patient was treated with CYTOTEC. Patient was hospitalized. Patient recovered.
METHERGINE problem was reported by a Pharmacist from UNITED STATES on Jan 17, 2007. Female patient, 25 years of age, weighting 173.9 lb, was diagnosed with postpartum haemorrhage, sepsis and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, body temperature increased, complication of delivery, cyanosis, dyspnoea, headache, oxygen saturation decreased, postpartum sepsis, tachycardia. METHERGINE dosage: 0.2 MG, ONCE/SINGLE. During the same period patient was treated with UNASYN. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported METHERGINE problem on Jan 17, 2007. Female patient, 39 years of age, weighting 146.0 lb, was diagnosed with postpartum haemorrhage, vaginal haemorrhage, prophylaxis and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: blood pressure immeasurable, body temperature decreased, body temperature increased, complication of delivery, cyanosis, dyspnoea, mental impairment, oxygen saturation decreased, pallor. METHERGINE dosage: 0.2 MG, ONCE/SINGLE. During the same period patient was treated with CYTOTEC, OXYTOCIN, PENICILLIN G, PENICILLIN G. Patient was hospitalized. Patient recovered.
METHERGINE problem was reported by a Health Professional from UNITED STATES on Oct 23, 2002. Female patient, child 2 years of age, weighting 29.98 lb, was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, hypotension, lethargy. METHERGINE dosage: 1.2 MG, ONCE/SINGLE, ORAL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported METHERGINE problem on Jan 21, 2007. Female patient was diagnosed with haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: haemorrhage. METHERGINE dosage: 0.125 MG, UNK. Patient recovered.
METHERGINE problem was reported by a Pharmacist from UNITED STATES on Feb 06, 2007. Male patient was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: hypotension, intubation, neonatal respiratory distress syndrome. METHERGINE dosage: 0.2 MG, ONCE/SINGLE. Patient recovered.
Health Professional from BRAZIL reported METHERGINE problem on Feb 05, 2007. Female patient, 18 years of age, weighting 99.21 lb, was diagnosed with menstrual disorder and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: headache, insomnia, nausea, syncope. METHERGINE dosage: 0.125 MG, TID. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from BRAZIL on Feb 09, 2007. Female patient, 25 years of age, weighting 167.6 lb, was diagnosed with postpartum haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, postpartum haemorrhage. METHERGINE dosage: 0.125 MG, QD. Patient recovered.
Consumer or non-health professional from FRANCE reported METHERGINE problem on Feb 19, 2007. Female patient, 35 years of age, was diagnosed with post abortion haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: hypertension, malaise, paraesthesia, tachycardia. METHERGINE dosage: unknown. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from BRAZIL on Feb 23, 2007. Female patient, 29 years of age, weighting 154.3 lb, was diagnosed with contraception, haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, fatigue, feeling abnormal, haemorrhage. METHERGINE dosage: unknown. Patient recovered.
Consumer or non-health professional from BRAZIL reported METHERGINE problem on Feb 23, 2007. Female patient, 34 years of age, weighting 138.9 lb, was diagnosed with uterine haemorrhage, dysmenorrhoea and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, uterine contractions abnormal, uterine haemorrhage. METHERGINE dosage: 0.125 MG, Q8H. During the same period patient was treated with PONSTAN. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from VENEZUELA on Mar 13, 2007. Female patient, 27 years of age, was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: paraesthesia, sensation of heaviness. METHERGINE dosage: 0.2 MG/ML, TID. During the same period patient was treated with FOLIC ACID. Patient recovered.
Physician from GERMANY reported METHERGINE problem on Mar 27, 2007. Female patient was diagnosed with menorrhagia and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: bone pain, dizziness, gastroenteritis, myalgia, nausea, tachycardia. METHERGINE dosage: unknown. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from BRAZIL on May 02, 2007. Female patient, 17 years of age, weighting 105.8 lb, was diagnosed with haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: abortion missed, headache, malaise. METHERGINE dosage: 0.125 MG, BID. Patient recovered.
Consumer or non-health professional from BRAZIL reported METHERGINE problem on May 02, 2007. Female patient, 17 years of age, weighting 105.8 lb, was diagnosed with haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: abortion missed, headache, malaise. METHERGINE dosage: 0.125 MG, BID. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from BRAZIL on May 02, 2007. Female patient, 17 years of age, weighting 105.8 lb, was diagnosed with haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: abortion missed, headache, malaise. METHERGINE dosage: 0.125 MG, BID. Patient recovered.
Health Professional from UNITED STATES reported METHERGINE problem on June 12, 2007. Female patient, weighting 209.0 lb, was diagnosed with migraine and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, nail bed tenderness, vasoconstriction. METHERGINE dosage: ONE 0.2 MG TABLET DAILY PO. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from BRAZIL on June 06, 2007. Female patient, weighting 140.0 lb, was diagnosed with haemorrhage, pain and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, uterine contractions during pregnancy. METHERGINE dosage: 0.125 MG, UNK. During the same period patient was treated with BUSCOPAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported METHERGINE problem on June 14, 2007. Female patient, 18 years of age, was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, cardiac failure, electrocardiogram st segment depression, tachycardia, ventricular hypokinesia. METHERGINE dosage: 0.2 MG, UNK. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from FRANCE on June 26, 2006. Female patient, weighting 7.72 lb, was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: convulsion neonatal, feeding disorder neonatal. METHERGINE dosage: 0.125 MG, TID. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported METHERGINE problem on July 19, 2006. Female patient, 22 years of age, was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: haemorrhage. METHERGINE dosage: unknown. Patient recovered.
METHERGINE problem was reported by a Pharmacist from JAPAN on July 25, 2006. Female patient was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: haematochezia. METHERGINE dosage: unknown. Patient recovered.
Consumer or non-health professional from BRAZIL reported METHERGINE problem on Aug 01, 2006. Female patient, 42 years of age, weighting 136.7 lb, was diagnosed with menstrual disorder and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: haemorrhage, hyperhidrosis, malaise, tremor, vomiting. METHERGINE dosage: unknown. Patient recovered.
METHERGINE problem was reported by a Health Professional from DENMARK on Sept 07, 2006. Female patient, 41 years of age, weighting 136.7 lb, was diagnosed with vaginal haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: anxiety, arrhythmia, discomfort, hallucination. METHERGINE dosage: unknown. Patient recovered.
Consumer or non-health professional from BRAZIL reported METHERGINE problem on Sept 22, 2006. Female patient, 32 years of age, was diagnosed with haemorrhage, hypothyroidism and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: burning sensation, hypersensitivity, pruritus, rash, skin exfoliation. METHERGINE dosage: 0.125 MG, Q8H. During the same period patient was treated with SYNTHROID. Patient recovered.
METHERGINE problem was reported by a Physician from GERMANY on Oct 29, 2006. Female patient was diagnosed with menorrhagia and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: bone pain, dizziness, myalgia, nausea, tachycardia. METHERGINE dosage: unknown. Patient recovered.
Consumer or non-health professional from BRAZIL reported METHERGINE problem on Nov 09, 2006. Female patient was diagnosed with post abortion haemorrhage, anaemia and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: haemorrhage. METHERGINE dosage: 0.125 MG, Q8H. During the same period patient was treated with FERROUS SULPHATE, KEFORAL. Patient recovered.
METHERGINE problem was reported by a Pharmacist from GERMANY on Nov 24, 2006. Female patient was diagnosed with vaginal haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia facial, microangiopathy, paraesthesia. METHERGINE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported METHERGINE problem on Dec 04, 2006. Female patient, 32 years of age, was diagnosed with caesarean section and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: rash papular. METHERGINE dosage: unknown. Patient was hospitalized. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from on June 19, 2007. Female patient, 33 years of age, weighting 138.9 lb, was diagnosed with haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: anaemia, headache, influenza, menorrhagia, vomiting. METHERGINE dosage: 0.125 MG, ONCE/SINGLE. Patient recovered.
Consumer or non-health professional from BRAZIL reported METHERGINE problem on July 16, 2007. Female patient was diagnosed with vaginal haemorrhage and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: intentional overdose, mood altered, nervousness. METHERGINE dosage: unknown. During the same period patient was treated with RIVOTRIL. Patient was hospitalized. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from BRAZIL on Aug 06, 2007. Female patient, 25 years of age, weighting 132.3 lb, was diagnosed with menorrhagia, contraception and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, abdominal pain, apathy, asthenia, deafness bilateral, malaise. METHERGINE dosage: 0.125 MG, Q8H. During the same period patient was treated with GALENIC. Patient recovered.
Consumer or non-health professional from BRAZIL reported METHERGINE problem on Aug 07, 2007. Female patient, 23 years of age, was diagnosed with intentional overdose, headache and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, intentional overdose, threatened labour. METHERGINE dosage: 1.875 MG, ONCE/SINGLE. During the same period patient was treated with BUSCOPAN. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from ITALY on Aug 17, 2007. Female patient was diagnosed with accidental exposure and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, restlessness, somnolence, vomiting. METHERGINE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported METHERGINE problem on Aug 17, 2007. Female patient was diagnosed with accidental exposure and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, anorexia, restlessness, somnolence, vomiting. METHERGINE dosage: unknown. Patient was hospitalized. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from ITALY on Aug 17, 2007. Female patient was diagnosed with accidental exposure and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, anorexia, restlessness, somnolence, vomiting. METHERGINE dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported METHERGINE problem on Aug 27, 2007. Female patient, 18 years of age, was diagnosed with uterine atony and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, cardiac failure, electrocardiogram st segment depression, hypokinesia, pneumothorax, tachycardia, troponin i increased, ventricular hypokinesia. METHERGINE dosage: 0.2 MG, ONCE/SINGLE. Patient recovered.
METHERGINE problem was reported by a Consumer or non-health professional from ITALY on Aug 24, 2007. Female patient was diagnosed with accidental exposure and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, anorexia, restlessness, somnolence, vomiting. METHERGINE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported METHERGINE problem on Sept 04, 2007. Female patient, 24 years of age, weighting 138.9 lb, was diagnosed with uterine atony and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, cold sweat, dizziness, dysstasia, hyperhidrosis, nausea, presyncope, tremor. METHERGINE dosage: 0.125 MG, TID. Patient recovered.
METHERGINE problem was reported by a Health Professional from BELGIUM on Sept 11, 2007. Female patient, 30 years of age, was diagnosed with hypotension and was treated with METHERGINE. After drug was administered, patient experienced the following problems/side effects: maculopathy, photopsia, reflexes abnormal, retinal vascular disorder, scotoma, vision blurred. METHERGINE dosage: unknown. During the same period patient was treated with ETILEFRINE. Patient recovered.